Cadence Secures $100 Million to Enhance Chronic Disease Management with AI
Cadence, a digital health startup, has successfully raised $100 million, achieving a valuation of $1.23 billion, to further its chronic disease management initiatives.
Editorial Staff
1 min read
Updated about 17 hours ago
Cadence, a startup in the digital health sector, has announced a significant funding round, securing $100 million to bolster its efforts in chronic disease management.
This funding elevates Cadence's valuation to $1.23 billion, reflecting growing investor interest in healthcare solutions that leverage artificial intelligence.
The company aims to use this capital to expand its program focused on automating care for chronic diseases, a critical area in healthcare.